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OBJECTIVE—Polymerase I and transcript release factor (PTRF)
is a protein highly expressed in adipose tissue and is an integral
structural component of caveolae. Here, we report on a novel role
of PTRF in lipid mobilization.
RESEARCH DESIGN AND METHODS—PTRF expression was
examined in different adipose depots of mice during fasting,
refeeding, and after administration of catecholamines and insulin.
Involvement of PTRF during lipolysis was studied upon PTRF
knockdown and overexpression and mutation of PTRF phos-
phorylation sites in 3T3-L1 adipocytes.
RESULTS—PTRF expression in mouse white adipose tissue
(WAT) is regulated by nutritional status, increasing during fasting
and decreasing to baseline after refeeding. Expression of PTRF
also is hormonally regulated because treatment of mice with
insulin leads to a decrease in expression, whereas isoproterenol
increases expression in WAT. Manipulation of PTRF levels
revealed a role of PTRF in lipolysis. Lentiviral-mediated knock-
down of PTRF resulted in a marked attenuation of glycerol
release in response to isoproterenol. Conversely, overexpressing
PTRF enhanced isoproterenol-stimulated glycerol release. Mass-
spectrometric analysis revealed that PTRF is phosphorylated at
multiple sites in WAT. Mutation of serine 42, threonine 304, or
serine 368 to alanine reduced isoproterenol-stimulated glycerol
release in 3T3-L1 adipocytes.
CONCLUSIONS—Our study is the ﬁrst direct demonstration for
a novel adipose tissue–speciﬁc function of PTRF as a mediator of
lipolysis and also shows that phosphorylation of PTRF is required
for efﬁcient fat mobilization. Diabetes 60:757–765, 2011
W
hite adipose tissue (WAT) plays a critical role
in energy homeostasis. Adipocytes store en-
ergy in the form of triacylglycerides (TAG)
during feeding and breakdown TAG during
fasting to release fatty acids and glycerol. TAG breakdown
(lipolysis) is regulated by lipolytic hormones, such as
catecholamines, whereas lipogenic hormones, such as in-
sulin, stimulate the synthesis of TAG and inhibit lipolysis
(1). Catecholamines stimulate lipolysis through increas-
ing cAMP levels and activating protein kinase A (PKA)
(2), whereas insulin inhibits lipolysis through activating
phosphodiesterase 3B, which causes degradation of cAMP
and loss of PKA activation (3). PKA phosphorylates target
proteins, including lipolytic enzymes, and lipid droplet–
associated proteins, including hormone-sensitive lipase
(HSL) and perilipin (4–6). Phosphorylated HSL translocates
from the cytosol to the surface of the lipid droplets where it
catalyses the hydrolysis of TAG together with adipose tri-
glyceride lipase (ATGL) (7).
Polymerase I and transcript release factor (PTRF), also
called cav-p60 and cavin, is a 50-kDa protein that is highly
expressed in smooth muscle, lung, and adipose tissue.
PTRF originally was identiﬁed in the nucleus of a mouse
embryonic ﬁbroblast cell line, where it plays a role in en-
hancing the transcriptional activity of polymerase I and
polymerase II (8,9). In addition to its nuclear localization,
PTRF is found at the cytoplasmic face of caveolae and is
the major caveolae-associated protein in primary human
adipocytes (10). Recently, PTRF was found to be required
for caveolae formation and may serve as a caveolar coat
protein together with caveolin-1 (11–13). Of note, it also
has been demonstrated that PTRF localizes speciﬁcally to
a caveolae subclass that metabolizes TAG (14,15), sug-
gesting a potential role of PTRF in TAG metabolism.
Moreover, PTRF interacts with HSL in primary human
adipocytes and translocates from the plasma membrane to
the cytosol in response to insulin treatment, suggesting
that PTRF may function in concert with HSL in the regu-
lation of lipolysis (16). Deletion of PTRF causes loss of
caveolae and dyslipidemia in mice (17). In humans, muta-
tions in the PTRF gene are associated with muscular dys-
trophy and lipodystrophy (18). These ﬁndings point to a
potential role of PTRF in regulating lipid metabolism in
adipose tissue.
PTRF is phosphorylated at multiple sites (19–23). In
primary human adipocytes, phosphorylation of PTRF at
multiple serine and threonine residues has been reported
(10,14). Insulin induces phosphorylation of PTRF on a tyro-
sine residue in adipocytes (24,25). However, the functional
signiﬁcance of PTRF phosphorylation has not previously
been characterized.
Here, we report that PTRF expression is under nutri-
tional and hormonal control in the WAT of mice. Fasting
and catecholamine treatment induce PTRF expression,
whereas refeeding and insulin administration reduce its
expression in WAT. Lentiviral-mediated reduction of PTRF
expression in 3T3-L1 adipocytes signiﬁcantly decreases
isoproterenol-stimulated glycerol release. Conversely,
overexpression of PTRF leads to increased isoproterenol-
stimulated glycerol release. Changes in PTRF expression
are accompanied by phosphorylation because PTRF is
phosphorylated during fasting and upon isoproterenol treat-
ment in adipocytes, and this phosphorylation is PKA de-
pendent. Mutation of serine 42, threonine 304, or serine 368
to alanine of PTRF leads to reduced isoproterenol-stimulated
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ORIGINAL ARTICLEglycerol release. Taken together, these data suggest that
PTRF plays a crucial role in lipolysis and that this function
is dependent on phosphorylation.
RESEARCH DESIGN AND METHODS
All procedures were approved by the Beth Israel Deaconess Medical Center
Institutional Animal Care and Use Committee. Male C57BL/6 mice, aged 18–20
weeks, were maintained in a temperature-controlled environment at 24 °C
under a 12-h light/12-h dark cycle (0600–1800 h) with ad libitum access to
a standard diet (F6 rodent diet; Harlan Teklad, Madison, WI) and water or
water alone when fasted. Mice were killed between 0900 and 1100 h and
rapidly dissected. Tissues were ﬂash-frozen for further analysis.
Cell culture and differentiation. 3T3-L1 cells were cultured in Dulbecco’s
modiﬁed Eagle’s medium (DMEM) (Invitrogen, Carlsbad, CA) with 10% bovine
calf serum at 5% CO2. Two days after conﬂuence was reached, cells were
differentiated by using 1 mmol/L dexamethasone (Sigma-Aldrich, St. Louis,
MO), 10 mg/mL insulin (Invitrogen), and 0.5 mmol/L isobutylmethylxanthine
(Sigma-Aldrich) in DMEM with 10% FBS and then maintained in medium
containing insulin for another 2 days. Cells were then maintained in DMEM
with 10% FBS until they were ready to be harvested. For insulin and iso-
proterenol experiments, adipocytes were incubated in serum-free DMEM
containing 2% BSA (Sigma-Aldrich) for 16 h then treated with insulin or iso-
proterenol for the times and at the concentrations indicated.
Overexpression, site-directed mutagenesis, and short-hairpin RNA–
mediated knockdown of PTRF. For overexpression of PTRF, full-length
PTRF cDNA were subcloned into a lentiviral expression vector pCDH-CMV-
EF1-Puro (System Biosciences, Mountain View, CA). Mutation of PTRF
phosphorylation sites to alanine was generated using the QuickChange II Site-
Directed Mutagenesis kit (Stratagene, La Jolla, CA) and PTRF–pCDH-CMV-
EF1-Puro as a template according to the manufacturer’s instructions. For
PTRF knockdown, ﬁve PTRF short-hairpin RNA (shRNA) constructs in lenti-
viral vector pLKO.1 were obtained from Open Biosystems (Huntsville, AL).
The construct chosen for the knockdown experiments was TRCN0000103575.
All lentiviral constructs were transfected into 293T cells using Lipofectamine 2000
(Invitrogen), along with packaging and envelope plasmids expressing gag, pol,
rev, and VSV-G genes, respectively. Supernatants were collected after 48 h. After
ﬁltration to remove cell debris, supernatants were added to 3T3-L1 adipocytes
at day 5 after differentiation, and cells were studied 5 days after infection.
RNA extraction and gene expression analysis. Total RNA was extracted
from cell lysates or homogenized tissues using an RNeasy Lipid Tissue kit for
PCR (Qiagen, Germantown, MD), followed by generation of cDNA using
a QuantiTect Reverse Transcription kit (Qiagen, Germantown, MD). Quanti-
tative real-time PCR was performed using the 7800HT (Applied Biosystems,
Foster City, CA) thermal cycler and SYBR-Green master mix (Applied Bio-
systems). Primers used were PTRF forward 59-AGTGAGCTCAAAGCCAGCAT-39,
reverse 59-GCCTTAGTTCCCCCAAAGAC-39, and 36B4 forward 59-AGATTCGG-
GATATGCTGTTGGC-39, reverse 59-TCGGGTCCTAGACCAGTGTTC-39. Relative
expression levels were calculated by the standard-curve method.
SDS-PAGE and immunoblotting. Proteins were extracted from adipose
tissue and 3T3-L1 cells in a radioimmunoprecipitation assay buffer containing
0.5 mmol/L Tris-HCl, pH 7.4; 150 mmol/L NaCl; 1 mmol/L EDTA; 1% NP40; 0.5%
sodium deoxycholate; 2 mmol/L sodium ortovanadate; 1 mmol/L sodium
ﬂuoride; 1 mmol/L sodium pyrophosphate; 2.5 mmol/L b-glycerolphosphate;
and protease inhibitors (Roche, Indianapolis, IN). Extracts were subjected to
SDS-PAGE (10.5–14% gels; Bio-Rad Laboratories, Hercules, CA) and trans-
ferred to nitrocellulose membranes (Millipore, Bedford, MA). After blocking,
membranes were incubated with mouse anti-PTRF (BD Transduction Labo-
ratories, San Jose, CA), guinea pig anti-perilipin, rabbit anti-HSL (Cell Sig-
naling Technology, Danvers, MA), rabbit anti–phospho-HSL (serine 660) (Cell
Signaling Technology), rabbit anti-caveolin-1 (BD Transduction Laboratories),
mouse anti-RAN (BD Transduction Laboratories), or mouse anti–b-actin
(Abcam, Cambridge, MA). Antibody binding was detected using secondary
antibodies conjugated to horseradish peroxidase, followed by chemilumines-
cence detection with SuperSignal West Pico Chemiluminescence Substrate
(Pierce, Rockford, IL).
Alkaline phosphatase treatment. Protein extracts from WAT were treated
with alkaline phosphatase (1 unit/mg protein) (New Englands Biolabs, Ipswich,
MA) for 1 h at 37°C.
Immunoprecipitation and liquid chromatography/tandem mass
spectrometry. Lysates were immunoprecipitated using mouse anti-PTRF
antibodies and collected using protein A/GPLUS-agarose beads (Santa Cruz
Biotechnology, Santa Cruz, CA). Immunoprecipitated proteins were solubilized
directly into Laemmli sample buffer. For all mass spectrometry (MS) experi-
ments, PTRF immunoprecipitates were separated using SDS-PAGE, and
a PTRF band was excised from Coomassie blue–stained gel. Samples were
subjected to reduction with dithiothreitol, alkylation with iodoacetamide,
and in-gel digestion with trypsin overnight at pH 8.3, followed by liquid
chromatography/tandem MS (LC/MS/MS) performed using EASY-nLC nano-
ﬂow high-performance liquid chromatography (Proxeon Biosciences, Odense,
Denmark) with a self-packed 75-mmi d3 15 cm C18 column connected to
a hybrid LTQ-Orbitrap XL mass spectrometer (Thermo Scientiﬁc, Waltham,
MA) in the data-dependent acquisition and positive-ion mode at 300 nL/min.
MS/MS spectra collected via collision-induced dissociation in the ion trap were
searched against the concatenated target and decoy (reversed) single-entry
PTRF and full Swiss-Prot protein databases using Sequest (Proteomics Browser
Software, Thermo Scientiﬁc) with differential modiﬁcations for serine/threonine/
tyrosine phosphorylation (+79.97). Phosphopeptide sequences were iden-
tiﬁed if they initially passed the following Sequest scoring thresholds against the
target database: 1 + ions, Xcorr $2.0 Sf $0.4, P $ 5; 2 + ions, Xcorr $2.0,
Sf $0.4, P $ 5; and 3 + ions, Xcorr $2.60, Sf $0.4, P $ 5 against the target
protein database. Passing MS/MS spectra were manually inspected to be sure
that all b- and y-fragment ions aligned with the assigned sequence and modiﬁ-
cation sites. Determination of the exact sites of phosphorylation was aided
using FuzzyIons and GraphMod, and phosphorylation site maps were created
using ProteinReport software (Proteomics Browser Software Suite, Thermo
Scientiﬁc). False-discovery rates of peptide hits were estimated below 1.25%
based on reversed database hits.
Lipolysis assays. For basal and stimulated lipolysis, adipocytes were serum
starved overnightand incubatedin thepresence orabsenceof isoproterenol for
the indicated time. Glycerol release was measured using the free glycerol
reagent kit (Sigma). Adipocytes were harvested in radioimmunoprecipitation
assay buffer containing protease inhibitors, and the protein content of cell
lysates was determined using the bicinchoninic acid protein assay kit (Pierce,
Rockford, IL). Glycerol levels were normalized with total cellular protein.
RESULTS
PTRF expression in adipose tissue is regulated by
nutritional status in mice in a depot-speciﬁc manner.
PTRF is highly expressed in adipose tissue (10). We ex-
amined its expression levels in different adipose depots in
mice. PTRF expression was depot speciﬁc, with the high-
est expression levels in gonadal adipose tissue compared
with subcutaneous, retroperitoneal, and brown adipose
tissue depots (Fig. 1A). Of note, no signiﬁcant difference in
PTRF protein expression was seen in any of the adipose
tissue depots of ob/ob mice compared with wild-type mice
(Supplementary Fig. 2). We next examined nutritional in-
ﬂuences on PTRF expression. In gonadal fat, expression of
PTRF was regulated by fasting and refeeding. Fasting for
48 h leads to a twofold induction in mRNA levels and
a ninefold increase in protein levels compared with fed
mice (Fig. 1B). The magnitude of PTRF mRNA changes
was lower than that seen in protein, suggesting that PTRF
expression is also modulated on the posttranscriptional
level. Refeeding resulted in a rapid reduction of PTRF
expression to fed levels within 1 h and remained at the
same levels throughout the refeeding time course (Fig. 1B).
The observed increase in PTRF expression in gonadal adi-
pose tissue was time dependent (Fig. 1C). Furthermore,
PTRF expression responds to nutritional manipulation in all
three WAT depots examined but not in brown adipose tis-
sue. Although PTRF expression levels increased after a 24-h
fast in WAT depots, including gonadal, subcutaneous, and
retroperitoneal, expression in brown adipose tissue did not
change upon fasting (Fig. 1D). A faster-migrating PTRF
band was observed (Fig. 1D), which is a result of well-
characterized proteolytic cleavages of PTRF in adipocytes
(10). We also observed a slower-migrating PTRF band
on SDS-PAGE in WAT upon fasting (Fig. 1C and D), sug-
gesting a posttranslational modiﬁcation of PTRF, such as
phosphorylation.
PTRF expression is regulated by insulin and
catecholamines in WAT. Insulin and catecholamines
play a role in the response of adipose tissue to fasting and
refeeding. We therefore evaluated the direct effects of
PTRF REGULATES LIPOLYSIS
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injected intraperitoneally with insulin (0.75 units/kg) or
isoproterenol (10 mg/kg), and the expression levels of
PTRF were measured 1-h postinjection. Insulin treatment
resulted in a twofold reduction of PTRF protein levels
compared with that in the WAT of saline-treated control
mice (Fig. 2A). Conversely, treatment with isoproterenol
resulted in a twofold increase in PTRF protein levels
in adipose tissue compared with controls (Fig. 2A). Iso-
proterenol treatment also induced a slower-migrating
PTRF band on SDS-PAGE (Fig. 2A) similar to that seen in
response to fasting (Fig. 1C and D), suggesting that PTRF
might undergo phosphorylation. The magnitude of PTRF
mRNA changes in response to hormonal treatment was
lower than changes in protein expression (Fig. 2B), again
suggesting a posttranscriptional regulation of PTRF.
Taken together, these results indicate that PTRF expres-
sion in WAT is under nutritional regulation and that this
tight regulation might be mediated directly by insulin and
catecholamine, suggesting a role of PTRF in lipolysis.
FIG. 1. PTRF expression is upregulated in WAT but not in brown adipose tissue upon fasting in mice. A: PTRF mRNA expression in gonadal
(Gonad), subcutaneous (Subc), retroperitoneal (Retro), and brown adipose tissue (Bat). B: PTRF mRNA (upper panel) and protein (bottom
panel) expression in gonadal adipose tissue from ad libitum–fed or fasted mice for 48 h or refed mice for the indicated time. C: PTRF expression
levels were determined by immunoblot in gonadal adipose tissue of ad libitum–fed or fasted mice for 12, 24, and 48 h. D: PTRF protein expression in
gonadal (Gonad), subcutaneous (Subc), retroperitoneal (Retro), and brown adipose tissue (Bat) of ad libitum–fed or fasted mice for 24 h. Gene
expression and protein expression were normalized to 36B4 and to actin, respectively (n =4 –8). Data are expressed as means 6 SE. *P < 0.05.
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We observed a slower-migrating PTRF band in WAT upon
fasting (Fig. 1C and D). This was reversed by alkaline
phosphatase treatment, suggesting that this shift in mobil-
ity is secondary to phosphorylation (Supplementary Fig. 1).
Using LC/MS/MS, we then identiﬁed the phosphorylation
sites of PTRF in the WAT of mice fasted for 24 h. Table 1
summarizes the identiﬁed phosphorylation sites of PTRF.
Four of the identiﬁed phosphorylation sites of PTRF,
namely serine 169, serine 171, threonine 304, and serine
368, were predicted to be phosphorylated by PKA when
analyzed by NetPhosK software (26), which is consistent
with the increased activity of PKA during fasting (27).
These data suggest a possible role of PTRF phosphoryla-
tion during TAG mobilization during fasting.
PTRF expression and phosphorylation is hormonally
regulated in 3T3-L1 adipocytes. Because 3T3-L1 adi-
pocytes provide a cell culture model system for studies of
lipolysis regulation, we used these cells to assess the role
of PTRF and its phosphorylation in lipolysis. We ﬁrst
conﬁrmed the in vivo data on PTRF regulation and phos-
phorylation. Consistent with the nutritional and hormonal
regulation of PTRF expression in vivo in WAT, PTRF ex-
pression in vitro in 3T3-L1 adipocytes also is regulated by
serum depletion, insulin, and catecholamine. Serum de-
pletion of 3T3-L1 adipocytes for 16 h resulted in a twofold
upregulation of PTRF protein levels (Fig. 3A, left panel).
The addition of insulin to serum-free media resulted in
a decrease of PTRF protein levels (Fig. 3A, right panel)i n
a dose-dependent manner (Fig. 3B). PTRF expression de-
creased by 50% compared with control levels (Fig. 3B). At
a concentration of 100 nmol/L insulin, reduction of PTRF
levels was ﬁrst seen after 2 h and persisted throughout the
24-h time course (Fig. 3C).
In contrast to insulin, isoproterenol treatment increased
PTRF protein levels with a peak at 1–2 h after treatment of
3T3-L1 adipocytes (Fig. 3D). PTRF levels remained ele-
vated from baseline up to 8 h after isoproterenol treatment
and decreased to basal levels between 8 and 24 h (data not
shown). PTRF also was phosphorylated in 3T3-L1 adipo-
cytes in response to isoproterenol treatment, as indicated
by the appearance of a slower-migrating PTRF band,
which ﬁrst appears at 0.1 mmol/L isoproterenol (Fig. 3E)
and within 30 min after the incubation of 3T3-L1 adipo-
cytes with 1 mmol/L isoproterenol (Fig. 3D). This slower-
migrating band disappeared almost completely 240 min
after isoproterenol incubation (Fig. 3D). This is in agree-
ment with the phosphorylation of PTRF in WAT in response
to fasting and isoproterenol treatment (Figs. 1 and 2).
Because isoproterenol induces lipolysis through acti-
vating PKA-dependent phosphorylation of lipolytic pro-
teins, including HSL and perilipin (1), we examined the
role of PKA on PTRF phosphorylation. Incubation of 3T3-
L1 adipocytes with isoproterenol in the presence and
absence of H89, a PKA inhibitor, substantially inhibited
isoproterenol-induced phosphorylation of PTRF (Fig. 3F).
Perilipin also migrates more slowly during SDS-PAGE
upon isoproterenol treatment as a result of phosphoryla-
tion by PKA on multiple sites (6). As expected, treatment
with H89 also reduced the PKA-induced phosphorylation
of perilipin (Fig. 3F). This indicates that PTRF undergoes
PKA-dependent phosphorylation upon isoproterenol treat-
ment of 3T3-L1 adipocytes, in agreement with our mass
spectrometric identiﬁcation of PKA-phosphorylation sites
in PTRF in WAT during fasting (Table 1).
Taken together, these in vitro results conﬁrm the
hormonal-regulated expression and phosphorylation of
PTRF seen in WAT.
Loss and gain of function of PTRF have opposite
effects on lipolytic activity in 3T3-L1 adipocytes. The
regulation of PTRF expression by insulin and catechol-
amines in adipocytes suggested a possible role for PTRF
in lipolysis. To assess such a potential role for PTRF, we
suppressed its expression by using lentiviral-driven shRNA
targeting PTRF in 3T3-L1 adipocytes. PTRF protein levels
were decreased by 45% compared with adipocytes infected
with the nontargeting control shRNA lentivirus (Shcont)
(Fig. 4A). Although basal rates of lipolysis were not af-
fected by PTRF knockdown, isoproterenol-stimulated li-
polysis, assayed by glycerol release, revealed a 30–40%
reduction following PTRF knockdown (Fig. 4B).
FIG. 2. PTRF expression is regulated by insulin and catecholamine in
gonadal adipose tissue. PTRF expression in gonadal adipose tissue of
mice fasted for 4 h and intraperitoneal injected with either saline (sal),
insulin (ins) (0.75 units/kg), or isoproterenol (iso) (10 mg/kg). Tissues
were harvest 1 h after injection. A: Immunoblot using PTRF antibodies
(upper panel). PTRF protein levels normalized to actin levels (bottom
panel). B: PTRF gene expression normalized to 36B4 expression (n =5 ) .
Data are expressed as means 6 SE. *P < 0.05; **P < 0.01. ns, not
signiﬁcant.
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infecting cells with lentivirus containing full-length PTRF
cDNA. PTRF protein levels increased twofold compared
with adipocytes infected with green ﬂuorescent protein
(GFP) control lentivirus (Fig. 4C). This was associated
with a 25–35% increase in isoproterenol-stimulated glyc-
erol release (Fig. 4D). PTRF overexpression had no effects
on the basal rate of lipolysis (Fig. 4D). These results are
consistent with a role for PTRF during lipolysis.
Mutation of speciﬁc PTRF phosphorylation sites
reduces lipolysis in 3T3-L1 adipocytes. We next ex-
amined the effects of PTRF phosphorylation on lipolysis.
We generated lentiviral constructs containing GFP as con-
trol, wild-type PTRF, or PTRF mutants in which PTRF
phosphorylation sites (Table 1) were mutated to alanine.
3T3-L1 adipocytes were infected with lentivirus, and the
effects of PTRF mutations were examined 5 days after in-
fection. Isoproterenol-stimulated lipolytic activity, as assayed
by glycerol release, was lower in adipocytes expressing
PTRF mutants S42A, T304A, and, S368A, when compared
with wild-type PTRF (Fig. 5A). On the other hand, no ef-
fect was seen in the PTRF mutants S21A, S169A, and
S171A, because they all showed similar lipolytic activity
as wild-type PTRF (Fig. 5A and data not shown). There
was no signiﬁcant effect of PTRF phosphorylation-site
mutations on basal lipolysis (Fig. 5A and Supplementary
Table 1). These results suggest that PTRF regulation of
isoproterenol-stimulated lipolysis is dependent on serine
and threonine phosphorylation of PTRF at Ser42, Thr304, or
Ser368 residues.
It is known that HSL, the key enzyme responsible for
lipolysis in WAT, interacts with PTRF (16) and that its
function during lipolysis also is dependent on PKA phos-
phorylation (28). To gain insight into the mechanisms by
which the mutation of PTRF phosphorylation sites sup-
presses lipolysis, we examined the phosphorylation status
of HSL in these cells. Notably, we found that the sup-
pressed lipolytic activity in adipocytes expressing the
PTRF mutations S42A, T304A, or S368A (Fig. 5A) was
accompanied by a reduction of HSL phosphorylation at
serine 563 and serine 660 (Fig. 5B). PKA-mediated phos-
phorylation of perilipin, on the other hand, was not af-
fected in cells expressing mutated phosphorylation sites of
PTRF (data not shown). In addition, there was no effect in
the PTRF mutants on HSL phosphorylation at serine 565
(data not shown), which has been shown to be a target for
AMP kinase but not PKA (28). Taken together, these data
indicate that phosphorylation of PTRF at serine 42, thre-
onine 304, or serine 368 is essential for the activation of
HSL by PKA during lipolysis.
DISCUSSION
Adipose tissue lipolysis is an important process in which
TAG are mobilized, releasing fatty acids and glycerol and
thus providing the body with substrates during fasting. The
dysregulation of lipolysis, which can occur in obesity or
lipodystrophic states, can lead to elevated levels of fatty
acids in the circulation, which is associated with an in-
creased risk for developing cardiovascular diseases and
diabetes. The lipolytic machinery is complex and includes
as central components perilipin, HSL, and ATGL, in addi-
tion to several factors and interacting proteins. Here,
we present data suggesting PTRF as a novel physiologi-
cally regulated and critical component of the lipolytic
machinery.
We found that levels of PTRF expression vary in dif-
ferent adipose tissue depots. Moreover, PTRF expression
is under strict hormonal and nutritional control in WAT but
not in brown adipose tissue. Although catecholamines and
fasting increase PTRF expression, insulin and refeeding
decrease its expression. This differential regional expres-
sion and regulation of PTRF might contribute to the met-
abolic heterogeneity observed among different adipose
depots (29,30). The induction of PTRF expression by
fasting and catecholamines in WAT supports with a role
of PTRF during lipid mobilization. Of note, PTRF also is
expressed in skeletal muscle, another tissue depot that
exhibits lipolytic activity. Future experiments will deter-
mine whether skeletal muscle PTRF also could be regu-
lated in a similar manner.
Consistent with nutritional and hormonal regulation, ma-
nipulation of PTRF expression in cultured cells also changed
lipid homeostasis. PTRF overexpression and knockdown
resulted in enhancement and suppression of lipolysis, re-
spectively. This is in line with PTRF subcellular location
at the lipid droplets and at TAG-synthesizing caveolae
subclass.
Lipolysis is an important process in which TAG are mo-
bilized, releasing fatty acids and glycerol and thus providing
the body with substrates during fasting. The lipolytic ma-
chinery is complex and includes as central components
TABLE 1
Identiﬁcation of PTRF phosphorylation sites in WAT by LC/MS/MS experimental and actual peptide sequence
Peptide sequence Site
Sequest ﬁnal
score MH+
Difference in
mass (ppm)
Sequest
cross-correlation
score DCn
Sequest
preliminary
score
PYSGFPDASsEGPEPTQGEAR Ser21 0.67 2258.9 20.3 4.5 0.05 404
ATEEPSGTGsDELIK Ser42 0.87 1613.7 23.1 4.03 0.07 1131
LPAKLsVSK Ser169 0.88 1022.6 0.4 3.34 0.22 390
VMIYQDEVKLPAKLSVsK Ser171 0.40 2128.1 27.1 3.48 0.08 151
SFtPDHVVYAR Thr304 0.59 1371.6 1.1 2.34 0.19 684
GSsPDVHTLLEITEESDAVLVDK Ser368 0.73 2534.2 2.6 4.69 0.17 486
PTRF was immunoprecipitated from the gonadal adipose tissue of mice fasted for 24 h. Peptides obtained from in-gel tryptic digestion of the
PTRF band were subjected to LC/MS/MS. Identiﬁed PTRF phosphopeptide sequences are listed below, along with the position of the
phosphorylation site in the PTRF sequence and relevant database search scores. Lowercase boldface s and t indicate phosphorylation at
serine and threonine, respectively. Phosphorylation at Ser42, Ser169, and Ser368 were previously identiﬁed, whereas Ser21, Ser171, and
Thr304 are novel PTRF phosphorylation sites. DCn, Sequest cross-correlation score difference between the top-ranked and next-best peptide
sequence.
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interacting proteins. Recently, both HSL and perilipin were
localized to TAG-synthesizing caveolae subclass (31). Other
lipolytic components, such as the b-adrenergic receptors, as
well as PKA also were found to associate with caveolar
membranes (32). It is therefore possible that PTRF, together
with other lipolytic proteins, facilitates lipolysis of TAG in
lipid droplets as well as in caveolae. This is consistent with
the ﬁnding that the localization of both PTRF and HSL in
caveolae is under insulin control, where insulin, which
inhibits lipolysis, induced translocation of both PTRF and
HSL from caveolae to the cytosol (16).
During fasting, hormones including catecholamines in-
duce lipolysis through binding to b-adrenergic receptors,
activating PKA, which phosphorylates perilipin and HSL
at multiple sites (5,28,33,34). PKA-dependent phosphory-
lation of HSL is necessary for docking of HSL at the sur-
face of lipid droplets and for activation of lipolysis (28).
However, localization of PTRF to caveolae in the plasma
membrane is not inﬂuenced by b-adrenergic stimulation
(16). Insulin, on the other hand, inhibits lipolysis through
activating phosphodiesterase 3B, which causes degrada-
tion of cAMP and loss of PKA activation (3). Our data
show that during lipolysis, PTRF also is phosphorylated by
PKA at multiple sites and that this PKA-dependent phos-
phorylation of PTRF plays an essential role during lipoly-
sis. A number of phosphorylation sites in the mouse and
human PTRF sequences have been previously identiﬁed.
However, the functional signiﬁcance of PTRF phosphory-
lation has not previously been characterized. Here, we
FIG. 3. PTRF expression is regulated by insulin and catecholamine in 3T3-L1 adipocytes. A: PTRF immunoblot of protein extracts from fully
differentiated 3T3-L1 adipocytes and incubated for 16 h in either 10% FSB (+) or serum-free (2) DMEM (left panel) or serum-free DMEM
supplemented with insulin at the concentrations indicated (right panel). B: Dose-response curve for PTRF protein expression were generated by
incubating 3T3-L1 adipocytes in serum-free DMEM supplemented with insulin at the indicated concentrations for 16 h (three experiments, n =3 ) .
C: Time course for PTRF protein expression were generated by incubating 3T3-L1 adipocytes in serum-free DMEM supplemented with 100 nmol/L
insulin for the indicated time. Data were normalized to actin and expressed relative to control cells. D: Time course for PTRF protein expression
was generated by incubating 3T3-L1 adipocytes in serum-free DMEM supplemented with 1 mmol/L isoproterenol for the indicated time. E: Dose-
response curves for PTRF protein expression were generated by incubating 3T3-L1 adipocytes in serum-free DMEM supplemented with iso-
proterenol at the indicated concentrations for 3 h (three experiments, n =3 ) .F: 3T3-L1 adipocytes were preincubated with the PKA inhibitor H89
(100 mmol/L) for 1 h prior to treatment with 1 mmol/L isoproterenol (Iso) for 1 h. Phosphorylation of PTRF is indicated by the appearance of an
additional PTRF band with slower migration in SDS-PAGE. Immunoblots were performed with the indicated antibody. Actin immunoblot was used
as a loading control. Data are expressed as means 6 SE. *P < 0.05; **P < 0.01.
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of PTRF phosphorylation, as mutation of PTRF at serine
42, threonine 304, or serine 368 to alanine signiﬁcantly
abrogated the lipolytic response in 3T3-L1 adipocytes.
In addition to phosphorylation, the action of HSL is de-
pendent on its interaction with other proteins such as
perilipin. This interaction is necessary for translocation of
HSL from the cytosol to the lipid droplets during lipolysis
(35). Furthermore, HSL interacts with the protein lipo-
transin, which docks HSL at the surface of the lipid
droplets (36). Because PTRF has been shown to interact
with HSL (16), it is possible that PTRF also serves as a
bridge between HSL and PKA to mediate phosphoryla-
tion and activation of HSL during lipolysis. Indeed, the
decrease in lipolysis in cells expressing the PTRF mutants
S42A, T304A, and S368A was accompanied by a reduction
in serine phosphorylation of HSL. Thus, phosphorylation
of PTRF is required for the subsequent phosphorylation of
HSL and initiation of lipolysis. It remains to be determined
whether the interaction between PTRF and HSL is phos-
phorylation dependent and whether PKA-phosphorylated
PTRF interacts with other lipolytic proteins. It also would
be of interest to determine whether PTRF itself had TAG
hydrolase activity or if it serves speciﬁcally to modulate
the activity of other hydrolases such as HSL.
Recent studies (11,12,17) have demonstrated that PTRF
is required for the formation of caveolae because knock-
down of PTRF leads to loss of caveolae. Loss of caveolae
was accompanied with rapid degradation of caveolin-1
protein (11). It is unlikely that caveolae biogenesis is af-
fected in cells expressing mutated phosphorylation sites of
PTRF because no effects were seen on caveolin-1 protein
expression in these cells (data not shown). However, it
would be interesting to determine whether PTRF phosphor-
ylation has an effect on caveolae morphology and dynamics.
Our study represents the ﬁrst direct demonstration of
nutritional and hormonal control of PTRF expression and
phosphorylation in adipose tissue in mouse. We provide
evidence for a novel adipose tissue-speciﬁc function of
PTRF as a critical mediator of lipolysis, which is a central
function of the adipocytes.
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